Cetuximab improves survival in patients with colorectal cancer

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Gastroenterology & Hepatology | 2008年 / 5卷 / 3期
关键词：
D O I：
10.1038/ncpgasthep1041
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：122 / 122
相关论文
共 50 条
  • [21] Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer
    Jiang, Di Maria
    Parshad, Shruti
    Zhan, Luna
    Sim, Hao-Wen
    Siu, Lillian L.
    Liu, Geoffrey
    Shapiro, Jeremy D.
    Price, Timothy J.
    Jonker, Derek J.
    Karapetis, Christos S.
    Strickland, Andrew H.
    Zhang, Wenjiang
    Jeffery, Mark
    Tu, Dongsheng
    Ng, Siobhan
    Sabesan, Sabe
    Shannon, Jenny
    Townsend, Amanda
    O'Callaghan, Chris J.
    Chen, Eric X.
    CLINICAL COLORECTAL CANCER, 2023, 22 (04) : 457 - 463
  • [22] Cetuximab for colorectal cancer
    Fraggetta, Filippo
    Pelosi, Giuseppe
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11): : 1196 - 1196
  • [23] Aspirin intake improves Survival of colorectal Cancer
    Reibetanz, J.
    Germer, C. T.
    CHIRURG, 2016, 87 (04): : 347 - 347
  • [24] Cetuximab plus irinotecan in refractory colorectal cancer patients
    Delgao, Marian Gil
    Spano, Jean-Philippe
    Khayat, David
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (04) : 407 - 413
  • [25] Molecular predictors of cetuximab resistance in colorectal cancer patients
    Finocchiaro, G.
    Cappuzz, F.
    Toschi, L.
    Rossj, E.
    Janne, P. A.
    Roncalli, M.
    Ligorio, C.
    Rimassa, L.
    Santoro, A.
    Varella-Garcia, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 141 - 141
  • [26] Intrinsic and acquired resistance to cetuximab in colorectal cancer patients
    Bray, Steven M.
    Lee, Jeeyun
    Kim, Seung Tae
    Ebert, Philip J.
    Calley, John N.
    Wulur, Isabella H.
    Gopalappa, Thejaswini
    Wong, Swee Seong
    Qian, Hui-Rong
    Ting, Jason C.
    Liu, Jiangang
    Willard, Melinda D.
    Aggarwal, Amit
    Novosiadly, Ruslan D.
    Kim, Hee-Cheol
    Reinhard, Christoph
    CANCER RESEARCH, 2017, 77
  • [27] Adjuvant Chemotherapy Improves Survival of Elderly Patients with Stage III Colorectal Cancer
    Smith, M. J.
    Mathieson, A.
    Turvosky, M.
    Haid, V.
    Ridgway, P. F.
    Smith, A. J.
    Ko, Y.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S76 - S76
  • [28] CETUXIMAB AS MONOTHERAPY IN ELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCER
    Esther, Una Cidon
    Tamas, Hickish
    Pilar, Alonso
    ANNALS OF ONCOLOGY, 2014, 25
  • [29] RADIOIMMUNOGUIDED SURGERY SYSTEM IMPROVES SURVIVAL FOR PATIENTS WITH RECURRENT COLORECTAL-CANCER
    BERTSCH, DJ
    BURAK, WE
    YOUNG, DC
    ARNOLD, MW
    MARTIN, EW
    SURGERY, 1995, 118 (04) : 634 - 639
  • [30] Cetuximab-induced hypomagnesemia in patients with colorectal cancer
    Fakih, Marwan G.
    Wilding, Gregory
    Lombardo, Jeffrey
    CLINICAL COLORECTAL CANCER, 2006, 6 (02) : 152 - 156
12345